167 related articles for article (PubMed ID: 34998000)
21. Comparative study of autoimplantation therapy and intralesional injection of MMR vaccine in warts treatment.
ElGhareeb MI
Dermatol Ther; 2019 Nov; 32(6):e13135. PubMed ID: 31648401
[TBL] [Abstract][Full Text] [Related]
22. Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases.
Al-Qassabi AM; Al Kindi A
Oman Med J; 2022 Mar; 37(2):e353. PubMed ID: 35356369
[TBL] [Abstract][Full Text] [Related]
23. Intralesional vitamin D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: A comparative case-control study.
Fathy G; Sharara MA; Khafagy AH
Dermatol Ther; 2019 Sep; 32(5):e12997. PubMed ID: 31225688
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Efficacy of Intralesional Measles, Mumps, and Rubella Vaccine with Intralesional Vitamin D3 as Immunotherapies in the Treatment of Recalcitrant Cutaneous Warts in Adult- A Randomized Placebo-Controlled Study.
Mohta A; Kushwaha RK; Agrawal A; Sharma MK; Gautam U; Jain SK
Indian Dermatol Online J; 2021; 12(6):879-887. PubMed ID: 34934726
[TBL] [Abstract][Full Text] [Related]
25. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
[TBL] [Abstract][Full Text] [Related]
26. Intralesional immunotherapy for non-genital warts: A systematic review and meta-analysis.
Ju HJ; Park HR; Kim JY; Kim GM; Bae JM; Lee JH
Indian J Dermatol Venereol Leprol; 2022; 88(6):724-737. PubMed ID: 35962514
[TBL] [Abstract][Full Text] [Related]
27. Intralesional Candida antigen versus intralesional vitamin D3 in the treatment of recalcitrant multiple common warts.
Abdel Razik LH; Obaid ZM; Fouda I
J Cosmet Dermatol; 2021 Oct; 20(10):3341-3346. PubMed ID: 34228877
[TBL] [Abstract][Full Text] [Related]
28. Comparative Study of Intralesional Vitamin D3 Injection and Candida Albicans Antigen in Treating Plantar Warts.
Abdelaal MA; Abdelaziz HM; Ahmed KA; Elsaie ML
J Drugs Dermatol; 2021 May; 20(5):546-549. PubMed ID: 33938709
[TBL] [Abstract][Full Text] [Related]
29. Intralesional injection of measles, mumps, and rubella vaccine versus cryotherapy in treatment of warts: A randomized controlled trial.
Abd El-Magiud EM; Abd El-Samea GM; Gaber HD
Dermatol Ther; 2020 Mar; 33(2):e13257. PubMed ID: 32031726
[TBL] [Abstract][Full Text] [Related]
30. A comparative evaluation of therapeutic response in warts to intralesional vitamin D3 versus intralesional measles, mumps, and rubella vaccine.
Singh AK; Devi KN; Bist JS
Dermatol Ther; 2022 Nov; 35(11):e15813. PubMed ID: 36088627
[TBL] [Abstract][Full Text] [Related]
31. Intralesional immunotherapy of plantar warts: report of a new antigen combination.
Gamil H; Elgharib I; Nofal A; Abd-Elaziz T
J Am Acad Dermatol; 2010 Jul; 63(1):40-3. PubMed ID: 20462659
[TBL] [Abstract][Full Text] [Related]
32. A Study of Comparison and Evaluation of Various Intralesional Therapies in Cutaneous Warts.
Chaudhary M; Brar A; Agarwal P; Chavda V; Jagati A; Rathod SP
Indian Dermatol Online J; 2023; 14(4):487-492. PubMed ID: 37521234
[TBL] [Abstract][Full Text] [Related]
33. Intralesional antigen immunotherapy for the treatment of plane warts: A comparative study.
Fawzy MM; Nofal A; Alakad R
Dermatol Ther; 2020 Nov; 33(6):e13807. PubMed ID: 32530550
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial.
Awal G; Kaur S
J Clin Aesthet Dermatol; 2018 May; 11(5):15-20. PubMed ID: 29785233
[No Abstract] [Full Text] [Related]
35. Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative.
Nofal A; Adel L; Fawzy M; Elkholy BM
Dermatol Ther; 2022 Jun; 35(6):e15440. PubMed ID: 35285995
[TBL] [Abstract][Full Text] [Related]
36. Treatment of recalcitrant warts with Bacillus Calmette-Guérin: a promising new approach.
Nofal A; Yosef A; Salah E
Dermatol Ther; 2013; 26(6):481-5. PubMed ID: 24552412
[TBL] [Abstract][Full Text] [Related]
37. Intralesional Purified Protein Derivative of Tuberculin Versus Intralesional Mycobacterium W Vaccine in Treatment of Recalcitrant Extragenital Warts: A Randomized, Single-Blinded, Comparative Study.
Mohta A; Jain SK; Mehta RD; Arora A
Indian J Dermatol; 2022; 67(1):26-30. PubMed ID: 35656274
[TBL] [Abstract][Full Text] [Related]
38. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
Marei A; Nofal A; Alakad R; Abdel-Hady A
J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869
[TBL] [Abstract][Full Text] [Related]
39. A Study to Evaluate the Role of Intradermal and Intralesional Measles, Mumps, Rubella (MMR) Vaccine in Treatment of Common Warts.
Gupta P; Tegta GR; Verma GK; Gupta A; Gupta M; Sharma S
Indian Dermatol Online J; 2020; 11(4):559-565. PubMed ID: 32832442
[TBL] [Abstract][Full Text] [Related]
40. Comparative Study of Efficacy of Intralesional Purified Protein Derivative (PPD) Versus Intralesional Measles, Mumps, and Rubella (MMR) Vaccine in Management of Multiple Viral Warts.
Bhalala KB; Poojary S; Shah KS
J Cutan Aesthet Surg; 2021; 14(4):397-403. PubMed ID: 35283602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
